PHEN Clinical Trials Rally

Increasing the participation of African American men in prostate cancer clinical trials through education, awareness, support and collaborations. This portal provides clinical trials background information, details for specific trials, personal stories and other resources to support the Rally.

This information is not intended as medical advice for patients. Patients should consult their medical doctor for advice and recommendations about specific clinical trials.


PHEN Clinical Trials Rally: A description including objectives and an outline of the activities.



Information

PHEN Clinical Trials Rally: The possible benefits for patients when participating in clinical trials.



Information

How Clinical Trials Aid African-Americans’ Fight with Prostate Cancer

PHEN president and founder Thomas A. Farrington talks about his prostate cancer journey.

Information




What Are Clinical Trials?


Information that all patients need to know when considering enrolling into a clinical trial. A description of what clinical trials are, outlining their purpose, who is involved, risks, benefits and more.

Information





Entering A Clinical Trial, Is It Right For You?


A Dana-Farber video to assist patients in understanding and making choices about clinical trials.

Information
Dr.'s Chiledum Ahaghotu, et al

African American Participation in Oncology Clinical Trials—Focus on Prostate Cancer:
Dr.'s Chiledum Ahaghotu, et al
"In addition to improving access to novel therapies, clinical trial participation is essential to adequately establish the risks and benefits of treatments in African American populations."

Information
Levi Garraway, MD, PhD

Precision Medicine Is Decoding the Mysteries of Cancer
Levi Garraway, MD, PhD
Dr. Garraway speaks on decoding the mysteries of cancer and developing new drugs and treatments to disarm this deadly disease.

Information

EMBARK

The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Information

ENACT

The primary purpose of this study is to compare the time to prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide versus patients undergoing active surveillance.

Information

ERA 223

To determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer which has spread to the bone, such as painful fractures or bone pain which needs to be treated with an X-ray machine. NOTE:THIS TRIAL IS NOW CLOSED TO ENROLLMENT.

Information

ARAMIS

The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.

Information

SPARTAN

Prostate Health Education Network The purpose of this study is to evaluate the efficacy and safety of ARN-509 in adult men with high-risk non-metastatic castration-resistant prostate cancer.

Information

ATLAS

The purpose of this study is to evaluate the efficacy and safety of an investigational medication in adult men with high risk, localized or locally advanced prostate cancer.

Information

TITAN

The purpose of this study is to evaluate the efficacy and safety of an oral investigational medication in adult men with metastatic, hormone-resistant prostate cancer.

Information

Prostate Cancer Clinical Trials

Information providing the purpose, description, eligibility criteria and status for prostate cancer clinical trials/studies in the United States that are currently recruiting patients.

Information






PHEN,Inc. © 2017 All rights reserved